Galecto Inc. (NASDAQ:GLTO) stock spiked on Tuesday, with a session volume of 61.11 million, compared to the average volume of 984,320, as per data from Benzinga Pro.However, there is no news to justify this extraordinary rally, suggesting speculative trading.As of June 30, 2025, cash and cash equivalents were approximately $10.2 million.The company anticipates that its cash and cash equivalents will be sufficient to fund operating expenses and capital requirements through 2026, including the submission of a ...

German automaker BMW has cut its 2025 earnings forecast due to slow growth in China and U.S. import tariffs, the company said in a statement on Tuesday. ...

Let's pull up shares of Oracle because it's a it's an interesting developing story uh as we have this conversation and you could see a little while ago these shares took a dip by about 5%. The information is out with a story today uh which says the following. I'm quoting directly from this story and this is the reason why the stock is lower.Uh internal documents show the fast growing cloud business has had razor thin gross profit margins in the past year or so, lower than what many equity analysts have esti ...

"The altcoin market represents some of blockchain's most innovative developments, but accessing these opportunities through traditional channels in the United States has been nearly impossible,†noted Jean- Marie Mognetti, CEO of CoinShares. "DIME changes that as part of our U.S. market expansion, bringing diversified altcoin exposure directly to American investors' brokerage accounts for the first time.†Primarily, DIME invests its assets towards assets that generate exposure to constituents of the CoinS ...

Active ETFs continue to rise in significance for investors, with flows on track for another record amid more and more launches. Amid that rise for the category, certain ETFs have stood out of late, the T. Rowe Price Health Care ETF (TMED) included. The fund is not only performing well in the last month, but also sending a buy signal according to its buy chart. See more: Investing in Biotech? Look to Active for Index Performance Dispersion TMED charges a 44 basis point fee to actively invest in healthcare st ...

NEW YORK (Reuters) -U.S. oil production is expected to hit a larger record this year than previously expected, the Energy Information Administration said on Tuesday, even as the agency warned that a glut of oil will weigh on prices in the months ahead. The Department of Energy's statistical arm expects U.S. oil production to average 13.53 million barrels per day this year, up from its prior forecast of 13.44 million bpd. Oil output averaged 13.23 bpd last year, which was the prior record. The anticipated ...

Information in Investor's Business Daily is for informational and educational purposes only and should not be construed as an offer, recommendation, solicitation, or rating to buy or sell securities. The information has been obtained from sources we believe to be reliable, but we make no guarantee as to its accuracy, timeliness, or suitability, including with respect to information that appears in closed captioning. Historical investment performances are no indication or guarantee of future success or perfo ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Key Takeaways MRK begins three phase IIb studies of tulisokibart in HS, r-axSpA and rheumatoid arthritis.Tulisokibart is now being tested across six types of immune-mediated inflammatory diseases.MRK's phase III pipeline has nearly tripled since 2021, boosting long-term growth potential.Merck (MRK) announced that it has initiated three separate phase IIb studies evaluating its investigational TL1A inhibitor, tulisokibart (MK-7240), in three new immune-mediated inflammatory diseases.The three new phase IIb s ...

Key Takeaways In the second quarter of 2025, MELI's total credit volume rose 91% year over year to reach $9.3 billion.Loans over 90 days past due remain elevated at 18.5%, indicating sustained strain on credit quality.Higher provisioning and funding costs could outpace income as the credit book expands faster than revenues.MercadoLibre’s (MELI) lending growth has reached a pace that now threatens its margin stability. The company’s credit book continues to swell far faster than profitability can keep up, ra ...